Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 202 of 5804
-
Could a cancer drug boost social abilities in rare genetic condition?
Disease control Not yet recruitingThe goal of this study is to examine the safety and treatment effects of everolimus in adults and children with PTEN Hamartoma Tumor Syndrome (PHTS) who experience social difficulties. The study will measure if everolimus can safely improve social abilities and functioning in thi…
Phase: PHASE2, PHASE3 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a pill supercharge brain stimulation for depression?
Disease control Not yet recruitingMajor depressive disorder (MDD) is a significant public health problem and leading cause of worldwide disability. Treatment resistance is common in MDD, however, for these individuals, targeted noninvasive brain stimulation is an alternative. Repetitive transcranial magnetic stim…
Phase: PHASE2, PHASE3 • Sponsor: NeuroRx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New injection combo takes aim at tough skin cancers
Disease control Recruiting nowOpen-label, single-arm, multicenter study in patients with locally advanced, histologically confirmed Cutaneous Squamous Cell Carcinoma (LacSCC) amenable to intratumoral injection, who have progressed on or are intolerant to Immune Checkpoint Inhibitor (ICI). The primary objectiv…
Phase: PHASE2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New Dual-Targeting cell therapy takes aim at Hard-to-Treat blood cancers
Disease control Not yet recruitingThis is a Phase 1 interventional, single-arm, open- label, treatment study designed to evaluate the safety of h20.19 CAR T cells in patients with B-cell malignancies that have failed prior therapies.
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New triple drug combo aims to slash cholesterol after heart attacks
Disease control Not yet recruitingEarly and intensive LDL-cholesterol (LDL-c) reduction is associated with improved short-term and long-term outcomes. Bempedoic acid is an oral ATP citrate lyase inhibitor that lowers LDL-c upstream of HMG-CoA reductase. When added to maximally tolerated statins, it has demonstrat…
Phase: PHASE3 • Sponsor: Heart Care Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New pill may cut blood transfusions for kids with thalassemia
Disease control Not yet recruitingThe primary objective of this study is to compare the effect of mitapivat versus placebo on transfusion burden in pediatric participants with α- or β-transfusion-dependent thalassemia.
Phase: PHASE3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New vaccine aims to cure chronic hepatitis b in early trial
⭐️ VACCINE ⭐️ Recruiting nowExisting nucleoside analogues (NAs) and interferon therapy for chronic hepatitis B (CHB) have limitations, including drug resistance, low HBsAg clearance rates, and irreversible immunosuppression. Therapeutic vaccines, by activating virus-specific T cells and B cells, hold promis…
Phase: PHASE1 • Sponsor: Jiyan Liu • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 03, 2026 00:00 UTC
-
New hope for tough leukemia: precision drug combo trial launches
Disease control Not yet recruitingTo evaluate the benefit of a precision medicine based strategy (targeted therapeutic options (TTOs)) for patients with relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) (in terms of composite remission).
Phase: PHASE2 • Sponsor: Philippe ROUSSELOT • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for stiff person syndrome: drug trial aims to ease muscle stiffness and improve walking
Symptom relief Not yet recruitingThe purpose of this study is to evaluate the efficacy and safety of QIVIGY (Intravenous Human Normal Immune Globulin 10%) compared with placebo in adult participants with stiff person syndrome (SPS).
Phase: PHASE3 • Sponsor: Kedrion S.p.A. • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Engineered immune cells take on brain cancer in early trial
Disease control TerminatedCentral nervous system lymphoma (CNSL) includes primary CNS lymphoma (PCNSL) and secondary CNS lymphoma (SCNSL), with diffuse large B-cell lymphoma as the predominant pathological type. Disease progression is often rapid and the relapse rate is high. Current standard treatment is…
Phase: PHASE1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a cocktail of antibiotics save babies born too early?
Disease control Not yet recruitingThe purpose of this study is to determine whether a combination of antibiotics (cephalosporin 3rd generation, clarithromycin, metronidazole) are effective to prolong pregnancies complicated with previable threatened labour with intact membranes.
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Magic mushroom compound takes on PTSD in major new trial
Symptom relief Not yet recruitingThe Redefine Study (COMP202) is testing COMP360 to see if it may reduce post-traumatic stress disorder (PTSD) symptoms when administered alongside monitoring and support from a trained study team. COMP360 is a lab-made form of the naturally occurring chemical compound psilocybin.
Phase: PHASE2, PHASE3 • Sponsor: COMPASS Pathways • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Saltwater solution could break deadly Heart-Kidney cycle
Disease control Not yet recruitingCongestive heart failure (CHF) remains a major cause of morbidity, rehospitalization, and mortality worldwide, particularly among elderly and polymorbid patients. Systemic congestion is its most characteristic clinical manifestation and the leading cause of hospitalization for ac…
Phase: PHASE3 • Sponsor: University of Monastir • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Ethiopian surgery infection study aims to save lives and limbs
Prevention Not yet recruitingThe study examines surgical site infections and antimicrobial resistance following life-saving surgeries like C-sections and leg fracture repairs in Ethiopia. It does not include healthy volunteers because it specifically focuses on patients who require these urgent operations du…
Sponsor: Karolinska Institutet • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
HIV-Positive livers for HIV-Positive patients: a new hope?
Disease control Not yet recruitingThis research is being done to better understand opportunistic infections and cancer in transplant recipients with HIV who receive livers from a donor with HIV compared to livers from donors without HIV.
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Glowing dye could help surgeons spot hidden epilepsy lesions
Disease control Not yet recruitingEpilepsy is one of the most common neurological disorders, with one of the highest morbidity rates of all diseases. Despite the development of new anticonvulsant drugs, around a third of patients suffer from drug-resistant epilepsy (RPE). The onset of RPE can be lengthy, prolongi…
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Spinal stimulation may steady blood pressure after spinal cord injury
Disease control Not yet recruitingThe purpose of this study is to learn whether stimulation applied to the spinal cord through the skin (called transcutaneous spinal stimulation) can help control blood pressure in people with a spinal cord injury. The main questions this study attempts to solve: 1. What are the…
Phase: NA • Sponsor: Kessler Foundation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Can a school-based trauma program keep incarcerated teens from turning to drugs?
Disease control Not yet recruitingThis pilot study, conducted in partnership with juvenile detention centers, evaluates an adapted CBITS-RTM intervention delivered in a detention school setting.
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Smartwatches may help heart patients avoid hospital readmission
Disease control Not yet recruitingWith the advancement of wearable technology, continuous non-invasive monitoring of vital signs, arrhythmia burden, and physical status has become increasingly feasible. Devices such as smartwatches and electrocardiogram (ECG) straps can provide real-time physiological data, offer…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a tiny implant seal large artery holes faster and safer?
Disease control Not yet recruitingThe objective of this study is to establish reasonable assurance of safety and effectiveness for the xDot Access Management System (AMS) when used as indicated for femoral-arterial and femoral-venous closure. Additionally, this study will provide preliminary evidence on the impac…
Phase: NA • Sponsor: xDot Medical, Inc • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC